| 000 | 02411 a2200661 4500 | ||
|---|---|---|---|
| 005 | 20250514005918.0 | ||
| 264 | 0 | _c20020205 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a0889-8588 | ||
| 024 | 7 |
_a10.1016/s0889-8588(05)70229-x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDiPaola, R S | |
| 245 | 0 | 0 |
_aTargeting apoptosis in prostate cancer. _h[electronic resource] |
| 260 |
_bHematology/oncology clinics of North America _cJun 2001 |
||
| 300 |
_a509-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aCaspases _xphysiology |
| 650 | 0 | 4 | _aCysteine Endopeptidases |
| 650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xgenetics |
| 650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
| 650 | 0 | 4 | _aFas Ligand Protein |
| 650 | 0 | 4 |
_aGene Expression Regulation, Neoplastic _xdrug effects |
| 650 | 0 | 4 | _aGenes, bcl-2 |
| 650 | 0 | 4 | _aGenes, p53 |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInterferons _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Glycoproteins _xphysiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Knockout |
| 650 | 0 | 4 |
_aMitochondria _xphysiology |
| 650 | 0 | 4 |
_aMultienzyme Complexes _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNF-kappa B _xphysiology |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xgenetics |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xtherapeutic use |
| 650 | 0 | 4 |
_aPhosphatidylinositol 3-Kinases _xphysiology |
| 650 | 0 | 4 | _aPhosphoinositide-3 Kinase Inhibitors |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aProteasome Endopeptidase Complex |
| 650 | 0 | 4 | _aProtein Serine-Threonine Kinases |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 | _aProto-Oncogene Proteins c-akt |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xphysiology |
| 650 | 0 | 4 |
_aRetinoids _xtherapeutic use |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xphysiology |
| 700 | 1 | _aPatel, J | |
| 700 | 1 | _aRafi, M M | |
| 773 | 0 |
_tHematology/oncology clinics of North America _gvol. 15 _gno. 3 _gp. 509-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0889-8588(05)70229-x _zAvailable from publisher's website |
| 999 |
_c11449493 _d11449493 |
||